Publications by authors named "Irene Boo"

Claim this Profile
F
Functional Antigen-Specific CD8 T Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection.
Yanran Zhao, Elizabeth Keoshkerian, Hui Li, Rachel Sacks-David, Irene Boo

Eur J Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell characteristics define HCV reinfection outcome.
Alexander P Underwood, Money Gupta, Bing-Ru Wu, Auda A Eltahla, Irene Boo

J Hepatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding.
Gemma E Hartley, Holly A Fryer, Paul A Gill, Irene Boo, Scott J Bornheimer

NPJ Vaccines· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological responses and clinical outcomes following a three-dose primary COVID-19 vaccine schedule in kidney transplant recipients and people on dialysis.
Dhakshayini Tharmaraj, Irene Boo, Jessie O'Hara, Shir Sun, Kevan R Polkinghorne

Clin Transl Immunology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy.
Anna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, Brendan L Harney, Irene Boo

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants.
Holly A Fryer, Gemma E Hartley, Emily S J Edwards, Nirupama Varese, Irene Boo

J Clin Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections.
Zihui Wei, Fiona Angrisano, Emily M Eriksson, Ramin Mazhari, Huy Van, Irene Boo

Immunol Cell Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core.
Pantelis Poumbourios, Christine Langer, Irene Boo, Tasnim Zakir, Rob J Center

PLoS Pathog· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2.
Gemma E Hartley, Emily S J Edwards, Nirupama Varese, Irene Boo, Pei M Aui

Allergy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
Joey McGregor, Joshua M Hardy, Chan-Sien Lay, Irene Boo, Michael Piontek

J Virol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2.
Thomas S Fulford, Huy Van, Nicholas A Gherardin, Shuning Zheng, Marcin Ciula, Irene Boo

EBioMedicine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.
Heidi E Drummer, Huy Van, Ethan Klock, Shuning Zheng, Zihui Wei, Irene Boo

medRxiv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
Gemma E Hartley, Emily S J Edwards, Pei M Aui, Nirupama Varese, Stephanie Stojanovic, Irene Boo

Sci Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine.
Rob J Center, Irene Boo, Lilian Phu, Joey McGregor, Pantelis Poumbourios

J Biol Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell immunodominance in primary hepatitis C virus infection.
Nicholas A Brasher, Auda A Eltahla, Alexander Underwood, Irene Boo, Simone Rizzetto

J Hepatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
Jun Gu, Joshua Hardy, Irene Boo, Patricia Vietheer, Kathleen McCaffrey

J Virol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
Dale Christiansen, Linda Earnest-Silveira, Brendon Chua, Irene Boo, Heidi E Drummer

Viral Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs.
Patricia T Vietheer, Irene Boo, Jun Gu, Kathleen McCaffrey, Stirling Edwards

Hepatology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
Kathleen McCaffrey, Irene Boo, Catherine M Owczarek, Matthew P Hardy, Matthew A Perugini

J Virol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calsyntenin-1 mediates hepatitis C virus replication.
Zunaira Awan, Enoch S E Tay, Nicholas S Eyre, Lindsay E Wu, Michael R Beard, Irene Boo

J Gen Virol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
Yousef Alhammad, Jun Gu, Irene Boo, David Harrison, Kathleen McCaffrey

J Virol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.
Irene Boo, Kevin teWierik, Florian Douam, Dimitri Lavillette, Pantelis Poumbourios

Biochem J· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.
Kathleen McCaffrey, Irene Boo, Kevin Tewierek, Mark L Edmunds, Pantelis Poumbourios

J Virol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.
Johanna Fraser, Irene Boo, Pantelis Poumbourios, Heidi E Drummer

J Biol Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
Kathleen McCaffrey, Hamed Gouklani, Irene Boo, Pantelis Poumbourios, Heidi E Drummer

J Gen Virol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis